| Cancer Chemotherapy
Updated: 07/29/2004
References
Physicians' Desk Reference.2004 58:1980-4.
Agarwal B, Rao CV, Bhendwal S, et al. Lovastatin augments sulindac-induced
apoptosis in colon cancer cells and potentiates chemopreventive effects
of sulindac. Gastroenterology. 1999 Oct;117(4):838-47.
Agha AM, El Fattah AA, Al Zuhair HH, et al. Chemopreventive effect of
Ginkgo biloba extract against benzo(a)pyrene-induced forestomach carcinogenesis
in mice: amelioration of doxorubicin cardiotoxicity. J Exp Clin Cancer
Res. 2001 Mar;20(1):39-50.
Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor
of angiogenesis. Mol Med. 1998 Jun;4(6):376-83.
Arteaga CL. Epidermal growth factor receptor dependence in human tumors:
more than just expression? Oncologist. 2002;7 Suppl 4:31-9.
Associated Press. .Arthritis Pills a Cancer Cure? (report on research
using COX-2 inhibitors in animal studies).2002;2002 Mar 30 Associated
Press.
Baxevanis CN, Tsavaris NB, Papadhimitriou SI, et al. Granulocyte-macrophage
colony-stimulating factor improves immunological parameters in patients
with refractory solid tumours receiving second-line chemotherapy: correlation
with clinical responses. Eur J Cancer. 1997 Jul;33(8):1202-8.
Berruti A, Dogliotti L, Tucci M, et al. Metabolic bone disease induced
by prostate cancer: rationale for the use of bisphosphonates. J Urol.
2001 Dec;166(6):2023-31.
Bhatia N, Agarwal R. Detrimental effect of cancer preventive phytochemicals
silymarin, genistein and epigallocatechin 3-gallate on epigenetic events
in human prostate carcinoma DU145 cells. Prostate. 2001 Feb 1;46(2):98-107.
Blasiak J, Gloc E, Wozniak K, et al. Genotoxicity of idarubicin and its
modulation by vitamins C and E and amifostine. Chem Biol Interact. 2002
Apr 20;140(1):1-18.
Blasina A, Price BD, Turenne GA, et al. Caffeine inhibits the checkpoint
kinase ATM. Curr Biol. 1999 Oct 7;9(19):1135-8.
Bounous G. Whey protein concentrate (WPC) and glutathione modulation in
cancer treatment. Anticancer Res. 2000 Nov;20(6C):4785-92.
Caro JJ, Salas M, Ward A, et al. Anemia as an independent prognostic factor
for survival in patients with cancer: a systemic, quantitative review.
Cancer. 2001 Jun 15;91(12):2214-21.
Chawla SP, Grunberg SM, Gralla RJ, et al. Establishing the dose of the
oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced
nausea and vomiting. Cancer. 2003 May 1;97(9):2290-300.
Chinery R, Brockman JA, Peeler MO, et al. Antioxidants enhance the cytotoxicity
of chemotherapeutic agents in colorectal cancer: a p53-independent induction
of p21WAF1/CIP1 via C/EBPbeta. Nat Med. 1997 Nov;3(11):1233-41.
Conti A, Maestroni GJ. The clinical neuroimmunotherapeutic role of melatonin
in oncology. J Pineal Res. 1995 Oct;19(3):103-10.
D'Agostini F, Bagnasco M, Giunciuglio D, et al. Inhibition by oral N-acetylcysteine
of doxorubicin-induced clastogenicity and alopecia, and prevention of
primary tumors and lung micrometastases in mice. Int J Oncol. 1998 Aug;13(2):217-24.
De Flora S, D'Agostini F, Masiello L, et al. Synergism between N-acetylcysteine
and doxorubicin in the prevention of tumorigenicity and metastasis in
murine models. Int J Cancer. 1996 Sep 17;67(6):842-8.
de Wit R, Herrstedt J, Rapoport B, et al. Addition of the oral NK1 antagonist
aprepitant to standard antiemetics provides protection against nausea
and vomiting during multiple cycles of cisplatin-based chemotherapy
16. J Clin Oncol. 2003 Nov 15;21(22):4105-11.
Edwards CJ, Hart DJ, Spector TD. Oral statins and increased bone-mineral
density in postmenopausal women. Lancet. 2000 Jun 24;355(9222):2218-9.
Edwards CJ, Russell RG, Spector TD. Statins and bone: myth or reality?
Calcif Tissue Int. 2001 Aug;69(2):63-6.
Faure H, Coudray C, Mousseau M, et al. 5-Hydroxymethyluracil excretion,
plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients.
Free Radic Biol Med. 1996;20(7):979-83.
Furst J, Haller T, Chwatal S, et al. Simvastatin inhibits malignant transformation
following expression of the Ha-ras oncogene in NIH 3T3 fibroblasts. Cell
Physiol Biochem. 2002;12(1):19-30.
Garcia-Moreno C, Mendez-Davila C, de La PC, et al. Human prostatic carcinoma
cells produce an increase in the synthesis of interleukin-6 by human osteoblasts.
Prostate. 2002 Mar 1;50(4):241-6.
Gately S, Kerbel R. Antiangiogenic scheduling of lower dose cancer chemotherapy.
Cancer J. 2001 Sep;7(5):427-36.
Hanahan D, Bergers G, Bergsland E. Less is more, regularly: metronomic
dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin
Invest. 2000 Apr;105(8):1045-7.
Hesketh PJ, Van Belle S, Aapro M, et al. Differential involvement of neurotransmitters
through the time course of cisplatin-induced emesis as revealed by therapy
with specific receptor antagonists
24. Eur J Cancer. 2003 May;39(8):1074-80.
Hesketh PJ, Grunberg SM, Gralla RJ, et al. The oral neurokinin-1 antagonist
aprepitant for the prevention of chemotherapy-induced nausea and vomiting:
a multinational, randomized, double-blind, placebo-controlled trial in
patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study
Group
9. J Clin Oncol. 2003 Nov 15;21(22):4112-9.
Holland JFFEIBRCJrPREWRR. Holland-Frei Cancer Medicine.2000 5th edition.
Hsueh CKDPSGK. Selective inhibition of cyclooxygenase-2 (COX-2) enhances
chemotherapy-induced apoptosis (meeting abstract). Proc Annu Meet Am Soc
Clin Oncol. 1999;(18):A606.
Hurley MM, Marcello K, Abreu C, et al. Signal transduction by basic fibroblast
growth factor in rat osteoblastic Py1a cells. J Bone Miner Res. 1996 Sep;11(9):1256-63.
Iarussi D, Auricchio U, Agretto A, et al. Protective effect of coenzyme
Q10 on anthracyclines cardiotoxicity: control study in children with acute
lymphoblastic leukemia and non-Hodgkin lymphoma. Mol Aspects Med. 1994;15
Suppl:s207-s212.
Ip C, Dong Y. Methylselenocysteine modulates proliferation and apoptosis
biomarkers in premalignant lesions of the rat mammary gland. Anticancer
Res. 2001 Mar;21(2A):863-7.
Jee SH, Shen SC, Tseng CR, et al. Curcumin induces a p53-dependent apoptosis
in human basal cell carcinoma cells. J Invest Dermatol. 1998 Oct;111(4):656-61.
Jiang X, Lim LY, Daly JW, et al. Structure-activity relationships for
G2 checkpoint inhibition by caffeine analogs. Int J Oncol. 2000 May;16(5):971-8.
Jung U, Zheng X, Yoon SO, et al. Se-methylselenocysteine induces apoptosis
mediated by reactive oxygen species in HL-60 cells. Free Radic Biol Med.
2001 Aug 15;31(4):479-89.
Jung YD, Kim MS, Shin BA, et al. EGCG, a major component of green tea,
inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma
cells. Br J Cancer. 2001 Mar 23;84(6):844-50.
Kawata S, Yamasaki E, Nagase T, et al. Effect of pravastatin on survival
in patients with advanced hepatocellular carcinoma. A randomized controlled
trial. Br J Cancer. 2001 Apr 6;84(7):886-91.
Keating A, Chez RA. Ginger syrup as an antiemetic in early pregnancy.
Altern Ther Health Med. 2002 Sep;8(5):89-91.
Kennedy RS, Konok GP, Bounous G, et al. The use of a whey protein concentrate
in the treatment of patients with metastatic carcinoma: a phase I-II clinical
study. Anticancer Res. 1995 Nov;15(6B):2643-9.
Kerbel RS, Klement G, Pritchard KI, et al. Continuous low-dose anti-angiogenic/
metronomic chemotherapy: from the research laboratory into the oncology
clinic. Ann Oncol. 2002 Jan;13(1):12-5.
Klement G, Baruchel S, Rak J, et al. Continuous low-dose therapy with
vinblastine and VEGF receptor-2 antibody induces sustained tumor regression
without overt toxicity. J Clin Invest. 2000 Apr;105(8):R15-R24.
Kobrinsky NL, Sjolander DE, Cheang MS, et al. Granulocyte-macrophage colony-stimulating
factor treatment before doxorubicin and cyclophosphamide chemotherapy
priming in women with early-stage breast cancer. J Clin Oncol. 1999 Nov;17(11):3426-30.
Kurbacher CM, Wagner U, Kolster B, et al. Ascorbic acid (vitamin C) improves
the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel
in human breast carcinoma cells in vitro. Cancer Lett. 1996 Jun 5;103(2):183-9.
Lissoni P, Paolorossi F, Ardizzoia A, et al. A randomized study of chemotherapy
with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin,
etoposide and the pineal hormone melatonin as a first-line treatment of
advanced non-small cell lung cancer patients in a poor clinical state.
J Pineal Res. 1997 Aug;23(1):15-9.
Lissoni P, Tancini G, Barni S, et al. Treatment of cancer chemotherapy-induced
toxicity with the pineal hormone melatonin. Support Care Cancer. 1997
Mar;5(2):126-9.
Lissoni P, Barni S, Mandala M, et al. Decreased toxicity and increased
efficacy of cancer chemotherapy using the pineal hormone melatonin in
metastatic solid tumour patients with poor clinical status. Eur J Cancer.
1999 Nov;35(12):1688-92.
Lissoni P. Is there a role for melatonin in supportive care? Support Care
Cancer. 2002 Mar;10(2):110-6.
Lissoni PAABSTGMMP. Immunotherapy with subcutaneous low-dose interleukin-2
plus melatonin as salvage therapy of heavily chemotherapy-pretreated ovarian
cancer. Oncol Rep. 1996;3(5):947-9.
Lou YR, Lu YP, Xie JG, et al. Effects of oral administration of tea, decaffeinated
tea, and caffeine on the formation and growth of tumors in high-risk SKH-1
mice previously treated with ultraviolet B light. Nutr Cancer. 1999;33(2):146-53.
Maestroni GJ, Covacci V, Conti A. Hematopoietic rescue via T-cell-dependent,
endogenous granulocyte-macrophage colony-stimulating factor induced by
the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res. 1994
May 1;54(9):2429-32.
Maestroni GJ, Conti A, Lissoni P. Colony-stimulating activity and hematopoietic
rescue from cancer chemotherapy compounds are induced by melatonin via
endogenous interleukin 4. Cancer Res. 1994 Sep 1;54(17):4740-3.
Maestroni GJ. kappa-Opioid receptors in marrow stroma mediate the hematopoietic
effects of melatonin-induced opioid cytokines. Ann N Y Acad Sci. 1998
May 1;840:411-9.
Man S, Bocci G, Francia G, et al. Antitumor effects in mice of low-dose
(metronomic) cyclophosphamide administered continuously through the drinking
water. Cancer Res. 2002 May 15;62(10):2731-5.
Matsumoto S, Imaeda Y, Umemoto S, et al. Cimetidine increases survival
of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl
Lewis-A epitope expression on tumour cells. Br J Cancer. 2002 Jan 21;86(2):161-7.
Michaels SBDM. In Vivo Assessment of NF-kB Inhibitors as Chemosensitizers:
Study 4967. Paper presented at the Annual Meeting of the American Association
for Cancer Research, New Orleans, March 24-28, 2001.2001;March 24-28,
2001 Study 4967.
Mortensen SA, Aabo K, Jonsson T, et al. Clinical and non-invasive assessment
of anthracycline cardiotoxicity: perspectives on myocardial protection.
Int J Clin Pharmacol Res. 1986;6(2):137-50.
Mukhopadhyay D, Tsiokas L, Zhou XM, et al. Hypoxic induction of human
vascular endothelial growth factor expression through c-Src activation.
Nature. 1995 Jun 15;375(6532):577-81.
Murray LS, Jodrell DI, Morrison JG, et al. The effect of cimetidine on
the pharmacokinetics of epirubicin in patients with advanced breast cancer:
preliminary evidence of a potentially common drug interaction. Clin Oncol
(R Coll Radiol ). 1998;10(1):35-8.
Narisawa T, Morotomi M, Fukaura Y, et al. Chemoprevention by pravastatin,
a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced
colon carcinogenesis in F344 rats. Jpn J Cancer Res. 1996 Aug;87(8):798-804.
Navis I, Sriganth P, Premalatha B. Dietary curcumin with cisplatin administration
modulates tumour marker indices in experimental fibrosarcoma. Pharmacol
Res. 1999 Mar;39(3):175-9.
Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al. Effect of fish oil, arginine,
and doxorubicin chemotherapy on remission and survival time for dogs with
lymphoma: a double-blind, randomized placebo-controlled study. Cancer.
2000 Apr 15;88(8):1916-28.
Papapoulos SE, Hamdy NA, van der PG. Bisphosphonates in the management
of prostate carcinoma metastatic to the skeleton. Cancer. 2000 Jun 15;88(12
Suppl):3047-53.
Pasco JA, Kotowicz MA, Henry MJ, et al. Statin use, bone mineral density,
and fracture risk: Geelong Osteoporosis Study. Arch Intern Med. 2002 Mar
11;162(5):537-40.
Paule B. [Interleukin-6 and bone metastasis of renal cancer: molecular
bases and therapeutic implications]. Prog Urol. 2001 Apr;11(2):368-75.
Pavlakis N, Stockler M. Bisphosphonates for breast cancer. Cochrane Database
Syst Rev. 2002;(1):CD003474.
Plummer SM, Holloway KA, Manson MM, et al. Inhibition of cyclo-oxygenase
2 expression in colon cells by the chemopreventive agent curcumin involves
inhibition of NF-kappaB activation via the NIK/IKK signalling complex.
Oncogene. 1999 Oct 28;18(44):6013-20.
Plunkett TA, Smith P, Rubens RD. Risk of complications from bone metastases
in breast cancer. implications for management. Eur J Cancer. 2000 Mar;36(4):476-82.
Poli-Bigelli S, Rodrigues-Pereira J, Carides AD, et al. Addition of the
neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy
improves control of chemotherapy-induced nausea and vomiting. Results
from a randomized, double-blind, placebo-controlled trial in Latin America
21. Cancer. 2003 Jun 15;97(12):3090-8.
Prasad KN, Hernandez C, Edwards-Prasad J, et al. Modification of the effect
of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma
cells in culture by a mixture of vitamins. Nutr Cancer. 1994;22(3):233-45.
Prasad KN, Kumar A, Kochupillai V, et al. High doses of multiple antioxidant
vitamins: essential ingredients in improving the efficacy of standard
cancer therapy. J Am Coll Nutr. 1999 Feb;18(1):13-25.
Prasad KN, Cole WC, Kumar B, et al. Scientific rationale for using high-dose
multiple micronutrients as an adjunct to standard and experimental cancer
therapies. J Am Coll Nutr. 2001 Oct;20(5 Suppl):450S-63S.
Pugliese PT, Jordan K, Cederberg H, et al. Some biological actions of
alkylglycerols from shark liver oil. J Altern Complement Med. 1998;4(1):87-99.
Pyo H, Choy H, Amorino GP, et al. A selective cyclooxygenase-2 inhibitor,
NS-398, enhances the effect of radiation in vitro and in vivo preferentially
on the cells that express cyclooxygenase-2. Clin Cancer Res. 2001 Oct;7(10):2998-3005.
Reyes-Moreno C, Sourla A, Choki I, et al. Osteoblast-derived survival
factors protect PC-3 human prostate cancer cells from adriamycin apoptosis.
Urology. 1998 Aug;52(2):341-7.
Ribeiro JC, Barnetson AR, Jackson P, et al. Caffeine-increased radiosensitivity
is not dependent on a loss of G2/M arrest or apoptosis in bladder cancer
cell lines. Int J Radiat Biol. 1999 Apr;75(4):481-92.
Sadzuka Y, Sugiyama T, Sonobe T. Efficacies of tea components on doxorubicin
induced antitumor activity and reversal of multidrug resistance. Toxicol
Lett. 2000 Apr 3;114(1-3):155-62.
Sadzuka Y, Sugiyama T, Sonobe T. Improvement of idarubicin induced antitumor
activity and bone marrow suppression by theanine, a component of tea.
Cancer Lett. 2000 Oct 1;158(2):119-24.
Sadzuka Y, Sugiyama T, Suzuki T, et al. Enhancement of the activity of
doxorubicin by inhibition of glutamate transporter. Toxicol Lett. 2001
Sep 15;123(2-3):159-67.
Schmidinger M, Budinsky AC, Wenzel C, et al. Glutathione in the prevention
of cisplatin induced toxicities. A prospectively randomized pilot trial
in patients with head and neck cancer and non small cell lung cancer.
Wien Klin Wochenschr. 2000 Jul 28;112(14):617-23.
Seol DW, Chen Q, Zarnegar R. Transcriptional activation of the hepatocyte
growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor)
is mediated through AP-1. Oncogene. 2000 Feb 24;19(9):1132-7.
Shariat SF, Shalev M, Menesses-Diaz A, et al. Preoperative plasma levels
of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression
in patients undergoing radical prostatectomy. J Clin Oncol. 2001 Jun 1;19(11):2856-64.
Sinha R, Medina D. Inhibition of cdk2 kinase activity by methylselenocysteine
in synchronized mouse mammary epithelial tumor cells. Carcinogenesis.
1997 Aug;18(8):1541-7.
Sinha R, Kiley SC, Lu JX, et al. Effects of methylselenocysteine on PKC
activity, cdk2 phosphorylation and gadd gene expression in synchronized
mouse mammary epithelial tumor cells. Cancer Lett. 1999 Nov 15;146(2):135-45.
Smith MR, McGovern FJ, Fallon MA, et al. Low bone mineral density in hormone-naive
men with prostate carcinoma. Cancer. 2001 Jun 15;91(12):2238-45.
Somasundaram S, Edmund NA, Moore DT, et al. Dietary curcumin inhibits
chemotherapy-induced apoptosis in models of human breast cancer. Cancer
Res. 2002 Jul 1;62(13):3868-75.
Sugiyama T, Sadzuka Y. Enhancing effects of green tea components on the
antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer
Lett. 1998 Nov 13;133(1):19-26.
Swamy MV, Cooma I, Reddy BS, et al. Lamin B, caspase-3 activity, and apoptosis
induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors:
a novel approach in developing effective chemopreventive regimens. Int
J Oncol. 2002 Apr;20(4):753-9.
Tajima M. [Chronic cardiotoxicity of anthracycline derivatives and possible
prevention by coenzyme Q10]. Gan No Rinsho. 1984 Jul;30(9 Suppl):1211-6.
Tatsuta M, Iishi H, Baba M, et al. Suppression by pravastatin, an inhibitor
of p21ras isoprenylation, of hepatocarcinogenesis induced by N-nitrosomorpholine
in Sprague-Dawley rats. Br J Cancer. 1998 Feb;77(4):581-7.
Tsai WS, Nagawa H, Muto T. Differential effects of polyunsaturated fatty
acids on chemosensitivity of NIH3T3 cells and its transformants. Int J
Cancer. 1997 Jan 27;70(3):357-61.
Tsai WY, Chang WH, Chen CH, et al. Enchancing effect of patented whey
protein isolate (Immunocal) on cytotoxicity of an anticancer drug. Nutr
Cancer. 2000;38(2):200-8.
Ura H, Obara T, Nishino N, et al. Cytotoxicity of simvastatin to pancreatic
adenocarcinoma cells containing mutant ras gene. Jpn J Cancer Res. 1994
Jun;85(6):633-8.
Valenzuela MT, Mateos S, Ruiz de Almodovar JM, et al. Variation in sensitizing
effect of caffeine in human tumour cell lines after gamma-irradiation.
Radiother Oncol. 2000 Mar;54(3):261-71.
van de Donk NW, Kamphuis MM, Lokhorst HM, et al. The cholesterol lowering
drug lovastatin induces cell death in myeloma plasma cells. Leukemia.
2002 Jul;16(7):1362-71.
Vanella A, Campisi A, di Giacomo C, et al. Enhanced resistance of adriamycin-treated
MCR-5 lung fibroblasts by increased intracellular glutathione peroxidase
and extracellular antioxidants. Biochem Mol Med. 1997 Oct;62(1):36-41.
Wagdi P, Fluri M, Aeschbacher B, et al. Cardioprotection in patients undergoing
chemo- and/or radiotherapy for neoplastic disease. A pilot study. Jpn
Heart J. 1996 May;37(3):353-9.
Wakeling AE, Guy SP, Woodburn JR, et al. ZD1839 (Iressa): an orally active
inhibitor of epidermal growth factor signaling with potential for cancer
therapy. Cancer Res. 2002 Oct 15;62(20):5749-54.
Waltregny D, Bellahcene A, de L, X, et al. Increased expression of bone
sialoprotein in bone metastases compared with visceral metastases in human
breast and prostate cancers. J Bone Miner Res. 2000 May;15(5):834-43.
Wang IK, Lin-Shiau SY, Lin JK. Suppression of invasion and MMP-9 expression
in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition
of ras isoprenylation. Oncology. 2000 Sep;59(3):245-54.
Yeo JK, Cha SD, Cho CH, et al. Se-methylselenocysteine induces apoptosis
through caspase activation and Bax cleavage mediated by calpain in SKOV-3
ovarian cancer cells. Cancer Lett. 2002 Aug 8;182(1):83-92.
You H, Yu W, Sanders BG, et al. RRR-alpha-tocopheryl succinate induces
MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation.
Cell Growth Differ. 2001 Sep;12(9):471-80.
Zhang F, Altorki NK, Mestre JR, et al. Curcumin inhibits cyclooxygenase-2
transcription in bile acid- and phorbol ester-treated human gastrointestinal
epithelial cells. Carcinogenesis. 1999 Mar;20(3):445-51. |